Zucara Therapeutics Expands ZT-01 Development Program to Type 2 Diabetes
November 02, 2020 07:30 ET
|
Zucara Therapeutics Inc.
TORONTO, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Zucara Therapeutics Inc. (“Zucara” or the “Company”), a diabetes life sciences company developing the first once-daily therapeutic to prevent...
Zucara Therapeutics Doses First Subject in Phase 1 Trial of ZT-01
September 29, 2020 07:30 ET
|
Zucara Therapeutics Inc.
TORONTO, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Zucara Therapeutics Inc., a diabetes life sciences company developing the first once-daily therapeutic to prevent insulin-induced hypoglycemia (low blood...
Zucara Therapeutics Announces US$21 Million Series A Financing
March 31, 2020 08:00 ET
|
Zucara Therapeutics Inc.
– Proceeds to Fund Development of ZT-01 Through Phase 2 Clinical Trials –– Series A Financing led by the Perceptive Xontogeny Venture Fund – TORONTO, March 31, 2020 (GLOBE NEWSWIRE) -- Zucara...